STIM Neuronetics, Inc. Insider Trading

10% Owner Chernett Jorey buys 100,000 shares of STIM at $1.17; stock down -75.5% from 52-week high, all 5 prior STIM trades unprofitable at 90-day mark

Chernett Jorey, a 10% owner, purchased 100,000 shares at $1.17 on 2026-05-19, increasing holdings from 10,453,988 to 10,553,988 shares. The stock has declined -24.7% over 30 days and trades -75.5% below its 52-week high of $4.85. More notably, Jorey's five prior purchases at STIM produced uniformly negative 90-day outcomes, with a 0 of 5 well-timed rate at the 90-day mark, suggesting a pattern of unfavorable timing at this specific ticker despite his cross-ticker track record averaging +28.6% over 90 days across 20 prior buys. The company is unprofitable (net income of $-10,790,000.00 for the latest quarter) while showing strong annual revenue growth of +99.2%, creating mixed fundamental signals that may explain continued accumulation by a significant shareholder in a depressed stock.

10% owner Chernett Jorey buys 475,000 shares at $1.34; stock now at $1.19, down 24.7% in 30 days; prior STIM buys 0 of 5 well-timed at 90d mark.

Chernett Jorey, a 10% owner, purchased 475,000 shares of Neuronetics at $1.34 on 2026-05-12, increasing holdings by 4.8% to 10.45M shares. However, the stock has declined to $1.19 (down 24.7% over 30 days and 75.5% from its 52-week high of $4.85), eroding the transaction value. More significantly, Jorey's prior five purchases at STIM show a consistent pattern of poor timing: none of the five earlier buys delivered positive 90-day returns, with losses ranging from -5.6% to -25.3% at the 90-day mark. While Jorey's cross-ticker track record shows a 60% 90-day win rate with +28.6% average return, this insider's execution at STIM has been markedly unsuccessful. The company remains unprofitable (net income $-10.8M in the latest quarter) despite 99.2% annual revenue growth, adding fundamental concern to the timing pattern.